Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4303 | White Sender in Acknowledgement Wiki | 1.00 |
| drug237 | African American Sender in Informational Videos. Wiki | 1.00 |
| drug3254 | Racial Inequality Highlighted Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug114 | AMA Acknowledgement Drug Pricing Wiki | 1.00 |
| drug4304 | White Sender in Informational Videos Wiki | 1.00 |
| drug236 | African American Sender Acknowledgement Wiki | 1.00 |
| drug197 | Acknowledgement Racial Injustice AMA Wiki | 1.00 |
| drug2988 | Placebo videos Wiki | 1.00 |
| drug291 | Angiotensin II Wiki | 0.71 |
| drug3728 | Standard of Care Wiki | 0.16 |
Navigate: Correlations HPO
There is one clinical trial.
The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also test the effect of concordance of providers and whether highlighting the unequal burden of the disease has additional effects on knowledge, beliefs and behavior regarding covid-19. The sample will include African American and white adult Americans and oversample those with less than a college degree.
Description: We discuss asymptomatic transmission as well as the common symptoms of cough, fever, shortness of breath and loss of taste/smell.
Measure: The number of participants with knowledge of COVID related symptoms and transmission as assessed by a questionnaire we've developed specifically relevant to the intervention videos we are using for the project. Time: immediately following the interventionDescription: We discuss asymptomatic transmission as well as the common symptoms of cough, fever, shortness of breath and loss of taste/smell.
Measure: The number of participants with knowledge of COVID related symptoms and transmission as assessed by a questionnaire we've developed specifically relevant to the intervention videos we are using for the project. Time: At a follow-up within 2 weeks following the interventionDescription: Specific behaviors include physical distancing, mask wearing and hand hygiene.
Measure: Behavioral outcome 1: Number of participants who report behavior change related to messages provided in the intervention videos; measured via a specific questionnaire instrument we've developed to correspond to the intervention. Time: immediately following the interventionDescription: Specific behaviors include physical distancing, mask wearing and hand hygiene.
Measure: Behavioral outcome 1: Number of participants who report behavior change related to messages provided in the intervention videos; measured via a specific questionnaire instrument we've developed to correspond to the intervention. Time: At a follow-up within 2 weeks following the interventionDescription: WTP: the participants will be asked to choose between two masks vs an unrestricted gift card. They will be asked what amount of gift card would make them just as happy to receive two mask versus the gift card.
Measure: Behavioral outcome 2: Willingness to pay (WTP) for masks Time: immediately following the interventionDescription: Links will include testing locations, state public health hotline and symptom tracker.
Measure: Behavioral outcome 3: Number of people who click on links for additional information on the covid-19 behaviors Time: immediately following the interventionDescription: The measurement tool are donations. The participant will be asked to decide how much of $1,000 (provided by the investigators) would be donated to two charity, one focusing on COVID relief and one on Alzheimer research.
Measure: Behavioral outcome 4: The amount of money donated to a COVID-19 relief fund. Time: immediately following the interventionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports